Physiology and Pathologies Linked to Human Splenic Function : Direct and Ex-vivo Perfusion Explorations

Status: Recruiting
Location: See all (5) locations...
Intervention Type: Other
Study Type: Observational
SUMMARY

Human splenic physiology remains poorly understood due to lack of functional exploration. However, through its ability to recognize alterations or modifications in circulating cells and to trigger an innate and adaptive response in response to these anomalies, the spleen plays a central role in several diseases affecting blood cells, directly or indirectly. The analysis of the splenic clearance of abnormal cells during ex-vivo perfusions made it possible to clarify the pathogenesis of malaria and the role of the spleen in the adaptive immune response. The study's investigative team wishes to extend these explorations to other human diseases in which the spleen is involved, and to evaluate the preventive or curative potential of substances that can modify the perception of blood cells by the spleen (e.g. monoclonal antibodies directed against circulating cells, among other options).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Adult patients

• Patient requiring left splenopancreectomy or planned splenectomy regardless of the method or indication

Locations
Other Locations
France
Hôpital Beaujon
RECRUITING
Clichy
Hôpital Necker-Enfants Malades
RECRUITING
Paris
Hôpital Pitié Salpêtrière
RECRUITING
Paris
Hôpital Saint Antoine
RECRUITING
Paris
Institut Pasteur
ACTIVE_NOT_RECRUITING
Paris
Contact Information
Primary
Pierre Buffet, MD, PhD
pierre.buffet@aphp.fr
Backup
Hélène Morel
helene.morel@aphp.fr
1 71 49 63 46
Time Frame
Start Date: 2016-10-16
Estimated Completion Date: 2031-10-16
Participants
Target number of participants: 100
Treatments
Patients
Adult patients cared in one of the APHP hospital (Necker-Enfants Malades Hospital, Saint-Antoine Hospital, Pitié Salpêtrière Hospital and Beaujon Hospital) for whom a splenic intervention (spleno-pancreectomy, or a total or partial splenectomy) is planned as part of their treatment.
Related Therapeutic Areas
Sponsors
Collaborators: URC-CIC Paris Descartes Necker Cochin, Institut Pasteur
Leads: Assistance Publique - Hôpitaux de Paris

This content was sourced from clinicaltrials.gov